Endocrine, Metabolic & Immune Disorders - Drug Targets is now the official Journal of Italian Medical Endocrinology Association
News release date: October 09, 2019
Bentham Science Publishers is pleased to announce that the journal Endocrine, Metabolic & Immune Disorders - Drug Targets (EMIDDT) is now the official journal of Associazione Medici Endocrinologi (AME), / Italian Medical Endocrinology Association. The journal is currently edited by Prof. Emilio Jirillo (University of Bari, Italy). Bentham Science Publishers wishes both the EMIDDT editorial board and AME society members a successful collaboration.
Associazione Medici Endocrinologi (AME) is a professional society born from the need to bring together those who work daily in the field of clinical endocrinology in Italy. AME promotes initiatives aimed at a constant growth of endocrinology as a discipline by improving medical guidelines, organizing meetings, developing cognitive tools for healthcare professionals and facilitating the publication of relevant research. Learn more about AME here.
Endocrine, Metabolic & Immune Disorders - Drug Targets (EMIDDT) journal is devoted to full-length/ mini reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome. Find out more about the journal here.